Cue Biopharma, Inc. (CUE)
27.88
-0.28
(-0.99%)
USD |
NASDAQ |
Aug 28, 16:00
28.18
+0.30
(+1.08%)
After-Hours: 20:00
Cue Biopharma Free Cash Flow : -50.17M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -50.17M |
| March 31, 2026 | -24.60M |
| December 31, 2025 | -21.86M |
| September 30, 2025 | -29.82M |
| June 30, 2025 | -28.32M |
| March 31, 2025 | -34.88M |
| December 31, 2024 | -36.40M |
| September 30, 2024 | -38.32M |
| June 30, 2024 | -38.60M |
| March 31, 2024 | -38.97M |
| December 31, 2023 | -39.96M |
| September 30, 2023 | -39.52M |
| June 30, 2023 | -38.67M |
| March 31, 2023 | -41.21M |
| December 31, 2022 | -41.98M |
| September 30, 2022 | -42.11M |
| Date | Value |
|---|---|
| June 30, 2022 | -41.80M |
| March 31, 2022 | -38.91M |
| December 31, 2021 | -39.75M |
| September 30, 2021 | -36.21M |
| June 30, 2021 | -37.61M |
| March 31, 2021 | -34.59M |
| December 31, 2020 | -33.09M |
| September 30, 2020 | -32.43M |
| June 30, 2020 | -33.62M |
| March 31, 2020 | -33.29M |
| December 31, 2019 | -30.84M |
| September 30, 2019 | -28.41M |
| June 30, 2019 | -25.79M |
| March 31, 2019 | -26.33M |
| December 31, 2018 | -28.27M |
| September 30, 2018 | -26.16M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Fortress Biotech, Inc. | 120.28M |
| Equillium, Inc. | -20.09M |
| Legend Biotech Corp. | -264.16M |
| Nurix Therapeutics, Inc. | -304.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.00M |
| Cash from Financing (Quarterly) | 30.02M |
| Free Cash Flow Per Share (Quarterly) | -4.574 |
| Free Cash Flow to Equity (Quarterly) | -34.37M |
| Free Cash Flow to Firm (Quarterly) | -29.00M |
| Free Cash Flow Yield | -39.56% |